Estimation of excess mortality from all causes during the Covid-19 pandemic in Mexico

被引：28

作者：

Sofia Palacio-Mejia, Lina ^{[1
]}

Leonel Wheatley-Fernandez, Jorge ^{[2
]}

Ordonez-Hernandez, Iliana ^{[3
]}

Lopez-Ridaura, Ruy ^{[4
]}

Gatell-Ramirez, Hugo Lopez ^{[5
]}

Hernandez-Avila, Mauricio ^{[6
]}

Eugenio Hernandez-Avila, Juan ^{[7
]}

机构：

[1] Inst Nacl Salud Publ, Catedra Conacyt, Cuernavaca, Morelos, Mexico

[2] Registro Nacl Poblac & Identidad, Direcc Gen, Ciudad De Mexico, Mexico

[3] Registro Nacl Poblac & Identidad, Ciudad De Mexico, Mexico

[4] Ctr Nacl Programas Preventivos & Control Enfermed, Direcc Gen, Ciudad De Mexico, Mexico

[5] Subsecretaria Prevenc & Promoc Salud, Ciudad De Mexico, Mexico

[6] Inst Mexicano Seguro Social, Direcc Prestn Econ, Ciudad De Mexico, Mexico

[7] Inst Nacl Salud Publ, Av Univ 655, Cuernavaca 62100, Morelos, Mexico

来源：

SALUD PUBLICA DE MEXICO | 2021年 / 63卷 / 02期

关键词：

excess mortality; Covid-19; Mexico; PREVALENCE;

D O I：

10.21149/12225

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Objective.To estimate excess mortality from all causes in Mexico in 2020.Materials and methods.We constructed an endemic channel with deaths (2015-2018) establishing the epidemic threshold at the 90th percentile, comparing with death certificates counts to estimate excess mortality. Results.At week 53, there were 326 612 excess deaths (45.1%), with a maximum in week 28 (98.0%) and a minimum at week 41 (35.2%); after week 42, the increasing trend remained for the rest of the year. It was proportionally higher in men, mainly aged 45-64 years, however, in those aged 60 and over, the highest number of deaths occurred. Conclusion. In Mexico, excess mortality has been prolonged compared to other countries, with high interstate variability.This could be explained by socioeconomic conditions and the high prevalence of comorbidities in the Mexican population.

引用

页码：211 / 224

页数：14

共 32 条

[1]

Adam S, 2020, Las actas sobre el numero real de muertos con COVID-19 en CDMX

[2]

[Anonymous], 2002, Plano De Acao Internacional Para o Envelhecimento

[3]

traducao de Arlene Santos, P49

[4] Excess mortality in Brazil in times of Covid-19 [J].

Azevedo e Silva, Gulnar ;

Jardim, Beatriz Cordeiro ;

Brito dos Santos, Cleber Vinicius .

CIENCIA & SAUDE COLETIVA, 2020, 25 (09) :3345-3354

[5] Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016 [J].

Basto-Abreu, Ana ;

Barrientos-Gutierrez, Tonatiuh ;

Rojas-Martinez, Rosalba ;

Aguilar-Salinas, Carlos A. ;

Lopez-Olmedo, Nancy ;

De la Cruz-Gongora, Vanessa ;

Rivera-Dommarco, Juan ;

Shamah-Levy, Teresa ;

Romero-Martinez, Martin ;

Barquera, Simon ;

Lopez-Ridaura, Ruy ;

Hernandez-Avila, Mauricio ;

Villalpando, Salvador .

SALUD PUBLICA DE MEXICO, 2020, 62 (01) :50-59

[6] Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? [J].

Beaney, Thomas ;

Clarke, Jonathan M. ;

Jain, Vageesh ;

Golestaneh, Amelia Kataria ;

Lyons, Gemma ;

Salman, David ;

Majeed, Azeem .

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2020, 113 (09) :329-334

[7]

BORTMAN M., 1999, Revista Panamericana de Salud Publica, V5, P8

[8]

Campbell A., 2020, COMP ALL CAUSE MORTA, P27

[9] Prevalence, diagnosis and control of hypertension in Mexican adults with vulnerable condition. Results of the Ensanut 100k. [J].

Campos-Nonato, Ismael ;

Hernandez-Barrera, Lucia ;

Flores-Coria, Alejandra ;

Gomez-Alvarez, Enrique ;

Barquera, Simon .

SALUD PUBLICA DE MEXICO, 2019, 61 (06) :888-897

[10]

Caro Vega YN, 2020, ANALISIS MORTALIDAD

← 1 2 3 4 →